Anson Funds Management’s Silo Pharma SILO Stock Holding History

Anson Funds Management’s Portfolio SILO Stock Details SILO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-63,492	Closed	-$657K	–	160
2025 Q3	$657K	Buy	+63,492	New	+$635K	0.06%	96

Other funds holding SILO

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Anson Funds Management's SILO Position: Q4 2025 in Review

Anson Funds Management sold out of Silo Pharma (SILO) in Q4 2025, closing a stake of 63,492 shares — an estimated $657K sold.

Anson Funds Management first reported a position in SILO in Q3 2025 and held it in 1 quarter. The position peaked at $657K in Q3 2025. 15 funds tracked by Wall St. Rank hold SILO as of Q4 2025.

Anson Funds Management reported no remaining Silo Pharma position as of Q4 2025 after selling out during the quarter.
Anson Funds Management sold 63,492 Silo Pharma shares in Q4 2025, an estimated $657K.
Anson Funds Management first reported a position in Silo Pharma in Q3 2025 and held it in 1 quarter.
Anson Funds Management's Silo Pharma position peaked at $657K in Q3 2025.
15 funds tracked by Wall St. Rank held Silo Pharma as of Q4 2025.

Based on Anson Funds Management's 13F filing for Q4 2025, filed 17 Feb 2026.